Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endothelin-1 as a Potential Trigger of Migraine Aura
NCT02906085Unknown
- Sponsor
- Rigshospitalet Glostrup
- Start
- Oct 2016
- Primary completion
- May 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine with aura comparing Endothelin-1 with Placebo (2 arms). Primary endpoint: Occurrence of migraine aura. Status: unknown.
02
Drugs
endothelin-1
03
Conditions
migraine with aura
Beyond the preview
Go deeper on NCT02906085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02906085.